<?xml version="1.0" encoding="UTF-8"?>
<p>In light of the previous studies summarized above, in this study, 
 <italic>N</italic> -(1-(4-methoxyphenyl)-3-oxo-3-((4-( 
 <italic>N</italic> -(substituted)sulfamoyl)phenyl)amino)prop-1-en-1-yl)benzamides 3aâ€“g having benzamide and primary or secondary sulfonamides pharmacophors were designed and their effects on hCA I, hCA II, and AChE enzymes were investigated in order to find out novel and effective enzyme inhibitors. 
</p>
